Hypertension

Show simple item record

dc.contributor.author Schellack, Natalie
dc.contributor.author Padayachee, N.
dc.date.accessioned 2023-02-07T10:06:10Z
dc.date.available 2023-02-07T10:06:10Z
dc.date.issued 2022
dc.description.abstract This article provides an overview of the changes that have taken place in the diagnosis and management of hypertension over the past decade. Hypertension remains a widespread condition seen in South Africa. The approach to managing hypertension includes necessary lifestyle modifications and a decisive, stepwise escalation process in the pharmacotherapeutic management thereof. Most guidelines are still promoting thiazide diuretics to be the initial (first-line) drug of choice, with the addition of other suitable antihypertensive agents, if necessary, and according to any relevant comorbid conditions. en_US
dc.description.department Pharmacology en_US
dc.description.librarian am2023 en_US
dc.description.uri http://www.sapj.co.za/index.php/sapj en_US
dc.identifier.citation Schellack, N. & Padayachee, N. 2022, 'Hypertension', SA Pharmaceutical Journal, vol. 89, no. 1, pp. 19-27. en_US
dc.identifier.issn 2221-5875 (print)
dc.identifier.issn 2220-1017 (online)
dc.identifier.uri https://repository.up.ac.za/handle/2263/89213
dc.language.iso en en_US
dc.publisher Medpharm Publications en_US
dc.rights © Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. en_US
dc.subject Hypertension en_US
dc.subject Antihypertensive agents en_US
dc.subject Fixed-dose combination therapy en_US
dc.subject Angiotensin II-receptor blockers en_US
dc.subject Angiotensin-converting enzyme inhibitors en_US
dc.subject Calcium-channel blockers en_US
dc.title Hypertension en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record